How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

The OncoDaily How I Treat series returns with a dedicated summit on head and neck cancers,  live on April 30, 2026, closing out Head and Neck Cancers Awareness Month.

Head and neck cancers represent more than 890,000 new diagnoses and over 450,000 deaths globally each year. Early-stage disease is often curable, yet a significant proportion of patients are diagnosed late, where outcomes remain poor. Immunotherapy, precision oncology, and advances in surgical and radiation techniques are transforming the field,  but the gap between emerging evidence and real-world practice persists.

This global virtual summit convenes leading experts to share practical, experience-based strategies for managing head and neck cancers across the full clinical spectrum in 2026.

Chairs

Images	Name
	Nagashree Seetharamu, MD, MBBS Chair Director of Thoracic and Head & Neck Medical Oncology at Northwell Health and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board-certified in medical oncology, hematology, and palliative medicine, she is a nationally recognized clinician-researcher with over 50 publications, principal investigator on multiple clinical trials, and an active leader within the Alliance for Clinical Trials in Oncology and the American Head and Neck Society. She also serves as a Board Member of OncoDaily
	Melvin Chua, MBBS, FRCR, PhD — Co-Chair Head of Department and Senior Consultant for Head & Neck and Thoracic Cancers in the Division of Radiation Oncology at the National Cancer Centre Singapore, and Associate Professor at Duke-NUS Medical School. A clinician-scientist specializing in nasopharyngeal carcinoma, he chairs the NPC Expert Panel for the AJCC/UICC TNM 9th Edition and leads the HNCIG Artificial Intelligence Working Group. He has published in the NEJM, Lancet, Nature, Cell, and JCO, and was conferred Fellow of ASCO in 2025.
	Amanda Psyrri, MD, PhD - Co-Chair Professor of Medical Oncology and Chair of Medicine at Attikon University Hospital, National Kapodistrian University of Athens, the largest clinical department in Greece. Trained at Yale, where she led translational research on HPV-driven head and neck carcinogenesis, she is a founding member of the Head and Neck Cancer Intergroup (HNCIG), Deputy Editor of Oral Oncology, and a member of the ESMO Council. Her research focuses on immunotherapy combinations and predictive biomarkers in HNSCC, with over 200 peer-reviewed publications.

Head and Neck Cancers Summit Speakers

Images	Name
	Nancy Lee Radiation Oncologist & Early Drug Development Specialist, Memorial Sloan Kettering, NY, USA
	Ari Rosenberg Medical Oncologist and Assistant Professor at the University of Chicago, USA
	Coral Olazagasti Assistant Professor at the Sylvester Cancer Center, University of Miami, Miami, Florida
	David Palma Radiation Oncologist at London Health Sciences Centre (LHSC), Clinician-Scientist with the Ontario Institute for Cancer Research, Chair of the Canadian Pulmonary Radiotherapy Investigators (CAPRI) Group, Canada
	Paolo Bossi Medical Oncologist and Associate Professor at the University of Brescia and ASST Spedali Civili di Brescia, Chair of the Mucositis Study Group at the Multinational Association of Supportive Care in Cancer (MASCC), and President of the Italian Network for Supportive Care in Oncology (NICSO), Brescia,Italy.
	Imperia Nuzzolese Medical oncologist specializing in Head and Neck Medical Oncology at the IRCCS Foundation National Cancer Institute of Milan, Italy
	David Lee Consultant Clinical Oncologist - Sunway Medical Centre, Malaysia
	Vaia Mentesidou Medical Oncologist, Research Fellow, Institut Gustave Roussy, France
	Laurent Ganry Head and Neck and Craniomaxillofacial Surgeon at Northwell Health, Long Island Jewish Medical Center, Associate Fellow of the American Academy of Craniomaxillofacial Surgeons (AACMFS), New York,  USA
	Vivek Ghosh Birat Cancer Institute, Biratnagar, Nepal Clinical Fellow, CancerCare Manitoba, Canada
	Aren Karapetyan Radiation Oncologist, Erebuni Radiotherapy Center, Armenia

Scientific Program

The program covers the full clinical pathway — from risk-stratified management of suspected and early-stage disease to evidence-based approaches in locally advanced and recurrent/metastatic settings. Sessions address systemic therapy selection, multidisciplinary coordination, organ preservation strategies, transoral and minimally invasive techniques, and advances in radiation therapy, with real-world perspectives on optimizing oncologic and functional outcomes across diverse healthcare systems.

How I Treat Head and Neck Cancers Event Details

Date: April 30, 2026
Format: Virtual Global Summit
Live Streaming: LinkedIn | YouTube | X

Registration is Open

A dedicated day focused on head and neck cancers science, clinical strategy, radiation techniques, surgical advances, and global perspectives, featuring expert voices from across continents.